Purchase Order 75N95019P00711
- Not listed
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $209,479.20 firm fixed-price purchase order to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract is for the delivery of assay kits. Quanterix has previously received over $30 million in federal contracts from agencies including the National Institutes of Health, Department of Veterans Affairs, and...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The contract, valued at $100,500.00, is for custom assay development services. Quanterix has received over $30 million in prior federal contracts from agencies including the National Institutes of Health,...
- This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The $149,000 firm-fixed-price purchase order is to analyze 9 human biomarkers from 1,122 samples. This work supports the NIH's research examining the relationship between inflammation and aging. Quanterix has been awarded over $30...
- The Department of Health and Human Services, National Institutes of Health awarded a firm fixed price purchase order to Quanterix Corporation, a for-profit manufacturer of goods, for the N4PA SIMOA 2.0 ASSAY KIT. The $112,969.08 award, with an October 2020 completion date, was not set aside. Quanterix has received over $30 million in prior federal contracts from agencies like the NIH, Department of Veterans Affairs, and Department of Defense to supply its ultra-sensitive digital biomarker...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Quanterix Corporation for the supply of Neurology 4-Plex A Advantage Kits, SR-X Disc Kits, and Wash Buffers, with a total value of $30,152.63. The award has a completion date of July 31, 2024. Quanterix is a life sciences company that specializes in ultra-sensitive digital biomarker detection technology, and has provided various products and services...
- This is a $19,170.11 firm-fixed-price purchase order contract awarded by the National Institute of Nursing Research, a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract is for the provision of Quanterix's Simoa (single molecule array) instruments, assay kits, and research services, which enable the measurement of proteins and other biomarkers at unprecedented levels of sensitivity. This supports...
- This firm-fixed-price purchase order was awarded by the National Institute of Nursing Research (NINR), a civilian agency under the National Institutes of Health (NIH), to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The $3,070.94 contract is for the procurement of Quanterix's Simoa (single molecule array) biomarker detection equipment and related maintenance services. Quanterix has received multiple federal contract awards...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Quanterix Corporation for a Quanterix SR-X Ultra-Sensitive Biomarker Detection System and related equipment and services. The total ceiling value of the contract is $89,500.00. This award is not associated with a set-aside program. Quanterix Corporation is a life sciences company that specializes in ultra-sensitive...
- This is a $119,614.50 firm-fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to Quanterix Corporation, a life sciences company that provides ultra-sensitive digital biomarker detection technology. The award is for Quanterix's Simoa 4-plex and Singleplex 96-well Plate Assays, including reagents, buffers, and shipping, to support the NIH's biomedical research programs. This is an unset-aside, commercial...
- This is a firm-fixed-price purchase order awarded by the National Institute of Nursing Research (NINR), a civilian agency, to Quanterix Corporation, a for-profit manufacturer of advanced biomedical equipment and research services. The $24,416.10 contract is for the supply of Quanterix's Simoa HD-X Analyzer, SR-X Biomarker Detection System, and related maintenance services. Quanterix is the prime contractor, and there are no set-aside designations mentioned. The contract award is not associated...
This is a firm-fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Quanterix Corporation, a life sciences company specializing in ultra-sensitive digital biomarker detection technology. The contract, valued at $99,653.76, is for the supply of assay kits. This award is not designated as a set-aside contract. Quanterix is the prime contractor and has not reported any major subcontractors for this award. The company has a history of federal government contracting, having received multiple awards from various agencies, including the National Institutes of Health (NIH), Department of Veterans Affairs (VA), and Department of Defense (DoD), to support biomedical research and diagnostic development. Quanterix's specialized capabilities in ultra-sensitive protein detection have been leveraged by these agencies to advance research in areas such as neurology, infectious diseases, and cancer.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $99.7k | 9/24/19 |